Advertisement
Screener

CYPHERPUNK TECHNOLOGIES INC. (CYPH) Basic Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

CYPHERPUNK TECHNOLOGIES INC. Basic Shares Outstanding (Weighted Average)

CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Basic Shares Outstanding (Weighted Average) of 184.33 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12

  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 184.33M shares, a 344.75% increase year-over-year.
  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 168.10M shares, a 307.34% increase year-over-year.
  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 140.40M shares, a 240.13% increase year-over-year.
  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 41.44M shares, a 0.57% increase year-over-year.
  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for fiscal 2025 was 66.14M shares, a 76.14% increase from fiscal 2024.
  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for fiscal 2024 was 37.55M shares, a 83.67% increase from fiscal 2023.
  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for fiscal 2023 was 20.45M shares, a 80.55% increase from fiscal 2022.
  • CYPHERPUNK TECHNOLOGIES INC. weighted average number of shares outstanding, basic for fiscal 2022 was 11.32M shares, a 86.81% decline from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 3 month as first filedWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 6 month as first filedWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 9 month as first filedWeighted Average Number of Shares Outstanding, Basic 12 monthWeighted Average Number of Shares Outstanding, Basic 12 month as first filed
2026-06-30184.33M shares
10-Q · filed 2026-08-12
176.26M shares
10-Q · filed 2026-08-12
164.28M shares
derived: average of 3 quarters · filed 2026-08-12
133.57M shares
derived: average of 4 quarters · filed 2026-08-12
2026-03-31168.10M shares
10-Q · filed 2026-05-14
154.25M shares
derived: average of 2 quarters · filed 2026-05-14
116.65M shares
derived: average of 3 quarters · filed 2026-05-14
97.85M shares
derived: average of 4 quarters · filed 2026-08-12
2025-12-31140.40M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
90.92M shares
derived: average of 2 quarters · filed 2026-03-16
74.43M shares
derived: average of 3 quarters · filed 2026-08-12
66.14M shares
10-K · filed 2026-03-16
2025-09-3041.44M shares
10-Q · filed 2025-11-12
41.44M shares
derived: average of 2 quarters · filed 2026-08-12
41.39M shares
10-Q · filed 2025-11-12
41.36M shares
derived: average of 4 quarters · filed 2026-08-12
2025-06-3041.44M shares
10-Q · filed 2026-08-12
41.36M shares
10-Q · filed 2026-08-12
41.33M shares
derived: average of 3 quarters · filed 2026-08-12
41.30M shares
derived: average of 4 quarters · filed 2026-08-12
2025-03-3141.27M shares
10-Q · filed 2026-05-14
41.27M shares
derived: average of 2 quarters · filed 2026-05-14
41.25M shares
derived: average of 3 quarters · filed 2026-05-14
40.72M shares
derived: average of 4 quarters · filed 2026-05-14
2024-12-3141.28M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
41.24M shares
derived: average of 2 quarters · filed 2026-03-16
40.54M shares
derived: average of 3 quarters · filed 2026-03-16
37.55M shares
10-K · filed 2026-03-16
2024-09-3041.21M shares
10-Q · filed 2025-11-12
40.17M shares
derived: average of 2 quarters · filed 2025-11-12
36.31M shares
10-Q · filed 2025-11-12
33.60M shares
derived: average of 4 quarters · filed 2025-11-12
2024-06-3039.12M shares
10-Q · filed 2025-08-14
33.83M shares
10-Q · filed 2025-08-14
31.07M shares
derived: average of 3 quarters · filed 2025-08-14
30.05M shares
derived: average of 4 quarters · filed 2025-08-14
2024-03-3127.01M shares
10-Q · filed 2025-05-13
27.04M shares
derived: average of 2 quarters · filed 2025-05-13
27.02M shares
derived: average of 3 quarters · filed 2025-05-13
23.94M shares
derived: average of 4 quarters · filed 2025-05-13
2023-12-3127.06M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26
27.02M shares
derived: average of 2 quarters · filed 2025-03-26
22.92M shares
derived: average of 3 quarters · filed 2025-03-26
20.45M shares
10-K · filed 2025-03-26
2023-09-3026.99M shares
10-Q · filed 2024-11-13
20.85M shares
derived: average of 2 quarters · filed 2024-11-13
18.24M shares
10-Q · filed 2024-11-13
16.49M shares
derived: average of 4 quarters · filed 2024-11-13
2023-06-3014.71M shares
10-Q · filed 2024-08-12
13.79M shares
10-Q · filed 2024-08-12
12.99M shares
derived: average of 3 quarters · filed 2024-08-12
12.57M shares
derived: average of 4 quarters · filed 2024-08-12
2023-03-3112.93M shares
10-Q · filed 2024-05-13
129.34M shares
10-Q · filed 2023-05-15
12.13M shares
derived: average of 2 quarters · filed 2024-05-13
11.86M shares
derived: average of 3 quarters · filed 2024-05-13
11.73M shares
derived: average of 4 quarters · filed 2024-05-13
2022-12-3111.32M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18
11.32M shares
derived: average of 2 quarters · filed 2024-03-18
11.32M shares
derived: average of 3 quarters · filed 2024-03-18
11.32M shares
10-K · filed 2024-03-18
113.24M shares
10-K · filed 2023-03-24
2022-09-3011.32M shares
10-Q · filed 2023-11-13
113.24M shares
10-Q · filed 2022-11-14
11.32M shares
derived: average of 2 quarters · filed 2023-11-13
11.32M shares
10-Q · filed 2023-11-13
113.24M shares
10-Q · filed 2022-11-14
62.33M shares
derived: average of 4 quarters · filed 2023-11-13
2022-06-3011.32M shares
10-Q · filed 2023-08-14
113.25M shares
10-Q · filed 2022-08-12
11.32M shares
10-Q · filed 2023-08-14
113.25M shares
10-Q · filed 2022-08-12
79.33M shares
derived: average of 3 quarters · filed 2023-08-14
79.05M shares
derived: average of 4 quarters · filed 2023-08-14
2022-03-31113.25M shares
10-Q · filed 2023-05-15
113.33M shares
derived: average of 2 quarters · filed 2023-05-15
101.63M shares
derived: average of 3 quarters · filed 2023-05-15
95.32M shares
derived: average of 4 quarters · filed 2023-05-15
2021-12-31113.41M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24
95.81M shares
derived: average of 2 quarters · filed 2023-03-24
89.34M shares
derived: average of 3 quarters · filed 2023-03-24
85.83M shares
10-K · filed 2023-03-24
2021-09-3078.22M shares
10-Q · filed 2022-11-14
77.30M shares
derived: average of 2 quarters · filed 2022-11-14
76.63M shares
10-Q · filed 2022-11-14
76.91M shares
derived: average of 4 quarters · filed 2022-11-14
2021-06-3076.39M shares
10-Q · filed 2022-08-12
76.38M shares
10-Q · filed 2022-08-12
76.48M shares
derived: average of 3 quarters · filed 2022-08-12
76.44M shares
derived: average of 4 quarters · filed 2022-08-12
2021-03-3176.38M shares
10-Q · filed 2022-05-13
76.52M shares
derived: average of 2 quarters · filed 2022-05-13
76.45M shares
derived: average of 3 quarters · filed 2022-05-13
70.45M shares
derived: average of 4 quarters · filed 2022-05-13
2020-12-3176.66M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
76.49M shares
derived: average of 2 quarters · filed 2022-03-11
68.48M shares
derived: average of 3 quarters · filed 2022-03-11
59.33M shares
10-K · filed 2022-03-11
2020-09-3076.32M shares
10-Q · filed 2020-11-12
64.38M shares
derived: average of 2 quarters · filed 2020-11-12
53.55M shares
10-Q · filed 2020-11-12
46.15M shares
derived: average of 4 quarters · filed 2021-03-12
2020-06-3052.44M shares
10-Q · filed 2020-08-13
42.04M shares
10-Q · filed 2020-08-13
36.10M shares
derived: average of 3 quarters · filed 2021-03-12
33.05M shares
derived: average of 4 quarters · filed 2021-03-12
2020-03-3131.63M shares
10-Q · filed 2020-05-14
27.92M shares
derived: average of 2 quarters · filed 2021-03-12
26.59M shares
derived: average of 3 quarters · filed 2021-03-12
25.67M shares
derived: average of 4 quarters · filed 2021-03-12
2019-12-3124.21M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
24.07M shares
derived: average of 2 quarters · filed 2021-03-12
23.68M shares
derived: average of 3 quarters · filed 2021-03-12
22.58M shares
10-K · filed 2021-03-12
2019-09-3023.92M shares
10-Q · filed 2020-11-12
23.41M shares
derived: average of 2 quarters · filed 2020-11-12
22.04M shares
10-Q · filed 2020-11-12
20.19M shares
derived: average of 4 quarters · filed 2020-11-12
2019-06-3022.91M shares
10-Q · filed 2020-08-13
21.08M shares
10-Q · filed 2020-08-13
18.95M shares
derived: average of 3 quarters · filed 2020-08-13
17.89M shares
derived: average of 4 quarters · filed 2020-08-13
2019-03-3119.24M shares
10-Q · filed 2020-05-14
16.97M shares
derived: average of 2 quarters · filed 2020-05-14
16.22M shares
derived: average of 3 quarters · filed 2020-05-14
2018-12-3114.71M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
14.71M shares
derived: average of 2 quarters · filed 2020-03-16
14.14M shares
10-K · filed 2020-03-16
2018-09-3014.70M shares
10-Q · filed 2019-11-14
13.96M shares
10-Q · filed 2019-11-14
2017-12-3110.89M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
10.14M shares
derived: average of 2 quarters · filed 2019-04-01
9.16M shares
10-K · filed 2019-04-01
2017-09-309.40M shares
10-Q · filed 2018-11-09
8.58M shares
10-Q · filed 2018-11-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06